Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.02
NYSE:HCA's Cash to Debt is ranked lower than
93% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. NYSE:HCA: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:HCA' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity to Asset -0.24
NYSE:HCA's Equity to Asset is ranked lower than
99% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. NYSE:HCA: -0.24 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:HCA' s Equity to Asset Range Over the Past 10 Years
Min: -0.5  Med: 0.2 Max: 0.42
Current: -0.24
-0.5
0.42
Interest Coverage 3.61
NYSE:HCA's Interest Coverage is ranked lower than
73% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 7.52 vs. NYSE:HCA: 3.61 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.09  Med: 2.3 Max: 3.61
Current: 3.61
1.09
3.61
F-Score: 7
Z-Score: 2.03
M-Score: -2.88
WACC vs ROIC
3.47%
17.96%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.78
NYSE:HCA's Operating margin (%) is ranked higher than
76% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 6.97 vs. NYSE:HCA: 14.78 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:HCA' s Operating margin (%) Range Over the Past 10 Years
Min: 7.48  Med: 13.02 Max: 15.86
Current: 14.78
7.48
15.86
Net-margin (%) 5.86
NYSE:HCA's Net-margin (%) is ranked higher than
56% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.69 vs. NYSE:HCA: 5.86 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:HCA' s Net-margin (%) Range Over the Past 10 Years
Min: 2.37  Med: 4.43 Max: 8.3
Current: 5.86
2.37
8.3
ROA (%) 7.34
NYSE:HCA's ROA (%) is ranked higher than
68% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. NYSE:HCA: 7.34 )
Ranked among companies with meaningful ROA (%) only.
NYSE:HCA' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 5.25 Max: 9.71
Current: 7.34
2.79
9.71
ROC (Joel Greenblatt) (%) 31.46
NYSE:HCA's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 19.96 vs. NYSE:HCA: 31.46 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:HCA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 19.55  Med: 30.17 Max: 37.66
Current: 31.46
19.55
37.66
Revenue Growth (3Y)(%) 9.00
NYSE:HCA's Revenue Growth (3Y)(%) is ranked higher than
56% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. NYSE:HCA: 9.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:HCA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 8.2 Max: 24.3
Current: 9
-7.8
24.3
EBITDA Growth (3Y)(%) 8.30
NYSE:HCA's EBITDA Growth (3Y)(%) is ranked higher than
54% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. NYSE:HCA: 8.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:HCA' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -10  Med: 8.2 Max: 39.4
Current: 8.3
-10
39.4
EPS Growth (3Y)(%) 12.70
NYSE:HCA's EPS Growth (3Y)(%) is ranked higher than
63% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. NYSE:HCA: 12.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:HCA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 6.9 Max: 88.4
Current: 12.7
0
88.4
» NYSE:HCA's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-27)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

HCA Guru Trades in Q3 2015

John Hussman 75,000 sh (New)
Jim Simons 516,400 sh (+705.62%)
Vanguard Health Care Fund 10,184,243 sh (+33.17%)
Larry Robbins 5,513,278 sh (+6.46%)
Mario Gabelli 27,225 sh (+0.83%)
John Paulson 4,711,900 sh (unchged)
Louis Moore Bacon Sold Out
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Steve Mandel Sold Out
Robert Olstein Sold Out
John Burbank Sold Out
David Dreman 25,802 sh (-8.95%)
David Tepper 3,553,537 sh (-15.08%)
Pioneer Investments 56,819 sh (-65.64%)
Paul Tudor Jones 7,800 sh (-77.46%)
» More
Q4 2015

HCA Guru Trades in Q4 2015

Richard Perry 3,063,000 sh (New)
First Pacific Advisors 49,770 sh (New)
Steven Cohen 109,300 sh (New)
George Soros 79,247 sh (New)
Joel Greenblatt 247,339 sh (New)
Louis Moore Bacon 130,000 sh (New)
Larry Robbins 14,300,549 sh (+159.38%)
David Tepper 4,537,063 sh (+27.68%)
Paul Tudor Jones 9,619 sh (+23.32%)
Vanguard Health Care Fund 11,911,153 sh (+16.96%)
Mario Gabelli 27,800 sh (+2.11%)
Samuel Isaly 1,220,500 sh (unchged)
Pioneer Investments Sold Out
John Paulson Sold Out
John Hussman Sold Out
David Dreman 22,684 sh (-12.08%)
Jim Simons 262,500 sh (-49.17%)
» More
Q1 2016

HCA Guru Trades in Q1 2016

Pioneer Investments 90,037 sh (New)
Jeremy Grantham 5,500 sh (New)
Lee Ainslie 369,220 sh (New)
Joel Greenblatt 622,232 sh (+151.57%)
Steven Cohen 247,800 sh (+126.72%)
Mario Gabelli 50,400 sh (+81.29%)
David Dreman 25,171 sh (+10.96%)
Larry Robbins 14,675,592 sh (+2.62%)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
George Soros Sold Out
First Pacific Advisors Sold Out
Paul Tudor Jones Sold Out
Vanguard Health Care Fund 11,682,053 sh (-1.92%)
Richard Perry 2,768,000 sh (-9.63%)
David Tepper 3,173,423 sh (-30.06%)
Samuel Isaly 1,107,100 sh (-9.29%)
» More
Q2 2016

HCA Guru Trades in Q2 2016

Andreas Halvorsen 1,089,482 sh (New)
John Hussman 100,000 sh (New)
Paul Tudor Jones 22,420 sh (New)
Jim Simons 574,500 sh (New)
Joel Greenblatt 916,670 sh (+47.32%)
Pioneer Investments 90,948 sh (+1.01%)
Mario Gabelli 50,400 sh (unchged)
Vanguard Health Care Fund 11,682,053 sh (unchged)
Richard Perry Sold Out
Steven Cohen Sold Out
Lee Ainslie Sold Out
David Dreman 25,075 sh (-0.38%)
Larry Robbins 14,586,992 sh (-0.60%)
Jeremy Grantham 3,900 sh (-29.09%)
David Tepper 1,216,940 sh (-61.65%)
Samuel Isaly 709,300 sh (-35.93%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:FMS, NYSE:DVA, OTCPK:FSNUY, NYSE:UHS, OTCPK:BDULF, OTCPK:MCFFY, OTCPK:SKHCF, NYSE:MD, OTCPK:CAKFY, NAS:WOOF, NAS:ACHC, NYSE:HLS, NAS:AMSG, OTCPK:NMHLY, OTCPK:HHCSY, OTCPK:LTGHY, NAS:LPNT, NYSE:CHE, NYSE:THC, NAS:SCAI » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 168 hospitals, comprised of 164 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. In addition, it operates 116 freestanding surgery centers. Its facilities are located in 20 states and England. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.

Ratios

vs
industry
vs
history
P/E(ttm) 13.04
HCA's P/E(ttm) is ranked higher than
83% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 24.63 vs. HCA: 13.04 )
Ranked among companies with meaningful P/E(ttm) only.
HCA' s P/E(ttm) Range Over the Past 10 Years
Min: 4.08  Med: 13.84 Max: 19.67
Current: 13.04
4.08
19.67
Forward P/E 10.64
HCA's Forward P/E is ranked higher than
91% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 17.86 vs. HCA: 10.64 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 13.04
HCA's PE(NRI) is ranked higher than
86% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 25.18 vs. HCA: 13.04 )
Ranked among companies with meaningful PE(NRI) only.
HCA' s PE(NRI) Range Over the Past 10 Years
Min: 4.08  Med: 13.84 Max: 19.67
Current: 13.04
4.08
19.67
Price/Owner Earnings (ttm) 10.43
HCA's Price/Owner Earnings (ttm) is ranked higher than
82% of the 88 Companies
in the Global Medical Care industry.

( Industry Median: 25.21 vs. HCA: 10.43 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HCA' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.27  Med: 12.23 Max: 58.95
Current: 10.43
6.27
58.95
P/S 0.77
HCA's P/S is ranked higher than
74% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. HCA: 0.77 )
Ranked among companies with meaningful P/S only.
HCA' s P/S Range Over the Past 10 Years
Min: 0.32  Med: 0.64 Max: 1.07
Current: 0.77
0.32
1.07
PFCF 10.86
HCA's PFCF is ranked higher than
81% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 22.61 vs. HCA: 10.86 )
Ranked among companies with meaningful PFCF only.
HCA' s PFCF Range Over the Past 10 Years
Min: 4.19  Med: 11.63 Max: 17.22
Current: 10.86
4.19
17.22
POCF 5.77
HCA's POCF is ranked higher than
86% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 14.37 vs. HCA: 5.77 )
Ranked among companies with meaningful POCF only.
HCA' s POCF Range Over the Past 10 Years
Min: 2.58  Med: 5.82 Max: 8.53
Current: 5.77
2.58
8.53
EV-to-EBIT 10.56
HCA's EV-to-EBIT is ranked higher than
85% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 20.23 vs. HCA: 10.56 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.8 Max: 12.6
Current: 10.56
6.3
12.6
EV-to-EBITDA 7.91
HCA's EV-to-EBITDA is ranked higher than
85% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 14.64 vs. HCA: 7.91 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.9 Max: 9.4
Current: 7.91
5
9.4
PEG 2.54
HCA's PEG is ranked higher than
55% of the 74 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. HCA: 2.54 )
Ranked among companies with meaningful PEG only.
HCA' s PEG Range Over the Past 10 Years
Min: 0.74  Med: 2.42 Max: 6.45
Current: 2.54
0.74
6.45
Shiller P/E 17.14
HCA's Shiller P/E is ranked higher than
72% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 28.53 vs. HCA: 17.14 )
Ranked among companies with meaningful Shiller P/E only.
HCA' s Shiller P/E Range Over the Past 10 Years
Min: 6.17  Med: 12.49 Max: 23.08
Current: 17.14
6.17
23.08
Current Ratio 1.69
HCA's Current Ratio is ranked higher than
64% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. HCA: 1.69 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.51 Max: 1.9
Current: 1.69
0.81
1.9
Quick Ratio 1.41
HCA's Quick Ratio is ranked higher than
57% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. HCA: 1.41 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.33 Max: 1.68
Current: 1.41
0.71
1.68
Days Inventory 76.24
HCA's Days Inventory is ranked lower than
85% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. HCA: 76.24 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 54.26  Med: 65.41 Max: 76.24
Current: 76.24
54.26
76.24
Days Sales Outstanding 50.86
HCA's Days Sales Outstanding is ranked lower than
60% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 43.71 vs. HCA: 50.86 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 53.01 Max: 56.3
Current: 50.86
44.84
56.3
Days Payable 104.39
HCA's Days Payable is ranked higher than
75% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. HCA: 104.39 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 104.39  Med: 112.98 Max: 119.5
Current: 104.39
104.39
119.5

Buy Back

vs
industry
vs
history
Yield on cost (5-Year) 0.30
HCA's Yield on cost (5-Year) is ranked lower than
97% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. HCA: 0.30 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HCA' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.3
3-Year Average Share Buyback Ratio 3.50
HCA's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. HCA: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.1  Med: 2.9 Max: 12
Current: 3.5
-4.1
12

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.51
HCA's Price/Projected FCF is ranked higher than
53% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 1.68 vs. HCA: 1.51 )
Ranked among companies with meaningful Price/Projected FCF only.
HCA' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.5  Med: 3.89 Max: 17.85
Current: 1.51
1.5
17.85
Price/DCF (Earnings Based) 1.22
HCA's Price/DCF (Earnings Based) is ranked higher than
69% of the 29 Companies
in the Global Medical Care industry.

( Industry Median: 1.59 vs. HCA: 1.22 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.20
HCA's Price/Median PS Value is ranked lower than
63% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. HCA: 1.20 )
Ranked among companies with meaningful Price/Median PS Value only.
HCA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.56  Med: 0.96 Max: 1.62
Current: 1.2
0.56
1.62
Price/Peter Lynch Fair Value 1.88
HCA's Price/Peter Lynch Fair Value is ranked higher than
64% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 2.33 vs. HCA: 1.88 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HCA' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.79  Med: 2.16 Max: 3.67
Current: 1.88
0.79
3.67
Earnings Yield (Greenblatt) (%) 9.53
HCA's Earnings Yield (Greenblatt) (%) is ranked higher than
89% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. HCA: 9.53 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HCA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 8  Med: 9.3 Max: 16
Current: 9.53
8
16
Forward Rate of Return (Yacktman) (%) 13.55
HCA's Forward Rate of Return (Yacktman) (%) is ranked higher than
66% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.20 vs. HCA: 13.55 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HCA' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9  Med: 13.15 Max: 17.6
Current: 13.55
9
17.6

More Statistics

Revenue (TTM) (Mil) $40,684
EPS (TTM) $ 5.78
Beta0.20
Short Percentage of Float3.26%
52-Week Range $60.07 - 83.69
Shares Outstanding (Mil)378.65

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 42,679 44,693 49,669
EPS ($) 6.47 7.04 8.03
EPS w/o NRI ($) 6.47 7.04 8.03
EPS Growth Rate
(3Y to 5Y Estimate)
12.02%
Dividends Per Share ($)
» More Articles for NYSE:HCA

Headlines

Articles On GuruFocus.com
David Tepper Exits Facebook, Boosts Allergan Aug 31 2016 
The Big 3: Larry Robbins' Top 2nd-Quarter Buys Aug 16 2016 
John Hussman Buys Infosys, Southern Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
Healthcare Growth Stocks in the S&P 500: Part 2 Aug 12 2016 
The “Bribing the Purchasing Agent Model" - Part I Jul 11 2016 
Richard Perry Trims Time Warner, AIG Jun 20 2016 
All-In-One Screener Finds Week's Largest Insider Trades May 13 2016 
Samuel Isaly's Eaton Vance Worldwide Health Sciences Fund Q1 Investment Report May 13 2016 
Value Stocks? Really? Apr 06 2016 

More From Other Websites
Zacks Investment Ideas feature highlights: Martin Marietta Materials, Guggenheim Solar ETF, First... Sep 28 2016
Struggling Hospital Cos. Quorum, LifePoint Next Up in Consolidation Push Sep 23 2016
Who might buy Community Health Systems (and who probably won't) Sep 19 2016
Why Junk Bonds Are Poised for a Correction (S, HLT) Sep 19 2016
Health-Services Spending Takes Off, Raising Political Risk Sep 09 2016
HCA Holdings, Inc. – Value Analysis (NYSE:HCA) : September 9, 2016 Sep 09 2016
5 Toxic Stocks to Stay Away From This Fall Sep 09 2016
Halvorsen Bought 13 New Holdings in 2nd Quarter Sep 08 2016
HCA Holdings, Inc. breached its 50 day moving average in a Bullish Manner : HCA-US : September 8,... Sep 08 2016
HCA Holdings Boosts Patient Care; to Buy Mobile Heartbeat Sep 07 2016
Hospital CEO resigns three months after appointment Sep 06 2016
HCA to Purchase Mobile Heartbeat Sep 06 2016
HCA to Purchase Mobile Heartbeat Sep 06 2016
Pasco hospital back in business, out millions in revenue Sep 06 2016
David Tepper Exits Facebook, Boosts Allergan Aug 31 2016
HCA to Present at September Healthcare Conferences Aug 31 2016
High-Yield Bond Funds Saw Inflows: Yields and Spreads Fell Aug 22 2016
Hospital Corporation of America: The Most Junk Bonds Last Week Aug 22 2016
Why High-Yield Bond Issuance Slowed Down Last Week Aug 19 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)